Main Article Content

Kar Param
Mohod Kanchan
Puttewar Manish
Kumar Satish


Background:  Oral  premalignancies  are  a  group  of  disease  or  syndromes  which  if  left untreated can lead to cancer. It carries a great significance in Indian perspective. The actual figure  of  oral  cancers  arising  from  oral  premalignancies  is  not  known  and  to  predict accurately the malignant transformations of them is still not possible. Oxidative stress is a known player behind cancerogenesis.  Recently decreased Paraoxonase-1 activity and increased oxidative stress markers ware found to be associated with Oral Squamous Cell Carcinoma. So, there is a strong possibility of a similar finding in Oral Premalignancies too. Aim:  This study aims to investigate the correlation between serum PON-1 activity and oxidative stress markers (MDA & Vitamin C) in patients with Oral Premalignancies. Material and Methods: A total of 62 patients with clinically diagnosed oral premalignant lesions and diseased controls were chosen for the study.  Venous blood samples were collected and PON-1, MDA (in serum) & Vitamin c (in plasma) were analysed spectro-photometrically. Results:   A   significant   decreased   serum   PON-1   activity   (P<0.05)   and   concomitant significantly increased serum MDA (P <0.05) and decreased Vitamin C levels (P<0.05) were observed in premalignancies compared to the controls. These finding were more pronounced in Oral Leukoplakia (OL) than in Oral Submucous Fibrosis (OSMF) with a significant difference. Mean levels of the analysed parameters differed accordingly in the clinical grades of oral premalignancies. Conclusion: It can be envisaged that serum PON-1 activity and increased oxidative stress might be a contributing factor behind pathogenesis and progression of Oral Premalignant Diseases.

Article Details

How to Cite
Param, K., Kanchan, M., Manish, P., & Satish, K. (2018). ASSESSMENT OF SERUM PARAOXONASE-1 ENZYME ACTIVITY, MALONDIALDEHYDE AND VITAMIN-C IN ORAL PREMALIGNANCIES. International Journal of Clinical and Biomedical Research, 4(3), 21-26.
Original Research Articles


1. Carnelio S, Rodrigues GS, Shenoy R, Fernandes D. A Brief Review of Common Oral Premalignant Lesions with Emphasis on Their Management and Cancer Prevention. The Indian Journal of Surgery. 2011;73(4):256-261.
2. Gururaj G, Girish N, Isaac MK. NCMH Background Papers-Burden of disease in India. New Delhi: Ministry of Health & Family Welfare. 2005
3. Markopoulos AK. Current aspects on oral squamous cell carcinoma. The open dentistry journal. 2012; 6:126.
4. Gupta S, Singh R, Gupta OP, Tripathi A. Prevalence of oral cancer and pre-cancerous lesions and the association with numerous risk factors in North India: A hospital based study. National Journal of Maxillofacial Surgery. 2014;5(2):142-148.
5. Katakwar P, Metgud R, Naik S, Mittal R. Oxidative stress marker in oral cancer: a review. Journal of cancer research and therapeutics. 2016;12(2):438.
6. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol.Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;321(17):1196-7.
7. Aksoy-Sagirli P, Cakmakoglu B, Isbir T, Kaytan-Saglam E, Kizir A, Topuz E, Berkkan H. Paraoxonase-1 192/55 polymorphisms and the risk of lung cancer in a Turkish population. Anticancer research. 2011; 31(6):2225-9.
8. Metin ZB, Aydin S, Unur M, Cakmakoglu B, Toptas B, Hafiz G, Ä°sbir T. Oral squamous cell carcinoma and serum paraoxonase 1. The Journal of Laryngology & Otology. 2013; 127(12):1208-13.
9. Gan KN, Smolen AN, Eckerson HW, La Du BN. Purification of human serum paraoxonase/ arylesterase. Evidence for one esterase catalyzing both activities. Drug Metabolism and Disposition. 1991;19(1):100-6
10. Buege JA, Aust SD. The thiobarbituric acid assay Metods Enzymmol 1978; 52:306-7.
11. Kyaw A. A simple colorimetric method for ascorbic acid determination in blood plasma. Clinica chimica acta. 1978 Jun 1; 86(2):153-7
12. Ghom AG, Ghom SA. Textbook of oral medicine. JP Medical Ltd; 2014 Sep 30,Chapter 12,Page 221
13. Warnakulasuriya S, Johnson N, Van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. Journal of oral pathology & medicine. 2007; 36(10):575-80.
14. Yardimci G, Kutlubay Z, Engin B, Tuzun Y. Precancerous lesions of oral mucosa.
World Journal of Clinical Cases : WJCC. 2014;2(12):866-872.
15. Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, Gupta PC, Mehta FS. Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol. 1985;13(6):340-1.
16. Petti S. Pooled estimate of world leukoplakia prevalence: A systemic review. Oral
Oncol. 2003;39:770-80
17. Mehta FS, Gupta PC, Daftary DK, Pindborg JJ, Choksi SK. An epidemiological study of oral cancer and precancerous condition among 101,761 villagers in Maharashtra, India. Int J Cancer. 1972;10:134–41.
18. Pindborg JJ, Chawla TN, Mishra RK, Nagpaul RK, Gupta VK. Frequency of oral carcinoma, leukoplakia, leukokeratosis, leukoedema, sub mucous fibrosis and lichen planus in 10,000 Indians in Lucknow, Uttar Pradesh India; Preliminary Report. J Dent Res. 1965;44:61.
19. Saran S, Agrawal GN. Cancer pattern in central U.P. Indian J Cancer. 1984;21(5):133-6.
20. Mackness B, Hunt R, Durrington PN, Mackness MI. Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein AI in the human artery wall with the progression of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. d1997; 17(7):1233-8.
21. Mouhamed DH, Ezzaher A, Mechri A, Neffati F, Omezzine A, Bouslama A, Gaha L, Douki W, Najjar MF. Effect of cigarette smoking on paraoxonase 1 activity according to PON1 L55M and PON1 Q192R gene polymorphisms. Environmental health and preventive medicine. 2012; 17(4):316-21
22. Chole RH, Patil RN, Basak A, Palandurkar K, Bhowate R. Estimation of serum malondialdehyde in oral cancer and precancer and its association with healthy individuals, gender, alcohol, and tobacco abuse. Journal of cancer research and therapeutics. 2010 Oct 1; 6(4):487.
23. Gupta S, Reddy MV, Harinath BC. Role of oxidative stress and antioxidants in aetiopathogenesis and management of oral submucous fibrosis. Indian journal of Clinical biochemistry. 2004 Jan 1; 19(1):138.
24. Metgud R, Bajaj S. Evaluation of salivary and serum lipid peroxidation, and glutathione in oral leukoplakia and oral squamous cell carcinoma. Journal of oral science. 2014; 56(2):135-42.
25. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A. 1989; 86(16):6377-81.
26. Basu S. Antioxidant Changes in Precancerous and Cancerous Lesions of Oral Cavity.
International Journal of Life Sciences Research. 2015; 3(1):23-28.
27. Tuovinen V, Väänänen M, Kullaa A, Karinpää A, Markkanen H, Kumpusalo E. Oral mucosal changes related to plasma ascorbic acid levels. Proc Finn Dent Soc.1992;88(3-4):117-22.
28. Rajendran R. Oral submucous fibrosis: etiology, pathogenesis, and future research.
Bulletin of the World Health Organization. 1994;72(6):985.